The effects of clonidine on the fear-inhibited light reflex

Journal of Psychopharmacology

Volumn 12, Issue 2, 1998, Pages 137-145

  Bitsios, P ^a   Szabadi, E ^a   Bradshaw, C M ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Anxiety; Clonidine; Fear; Healthy volunteers; Light reflex; Pupil

Indexed keywords

ANXIOLYTIC AGENT; CLONIDINE;

ADULT; ALERTNESS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTRIC SHOCK; FEAR; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PUPIL; PUPIL REFLEX; SYSTOLIC BLOOD PRESSURE; TRANQUILIZING ACTIVITY;

ADULT; ANTI-ANXIETY AGENTS; ANXIETY; AROUSAL; CLONIDINE; DIAZEPAM; DOUBLE-BLIND METHOD; ELECTROSHOCK; FEAR; HUMANS; MALE; NEURAL INHIBITION; REFLEX, PUPILLARY; SYMPATHOLYTICS;

EID: 0031864369     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119801200204     Document Type: Article

References (43)

1. Abduljawad K A J, Langley R W, Bradshaw C M, Szabadi E (1997) Effects of clonidine and diazepam on the acoustic startle response and on its inhibition by 'prepulses' in man. J Psychopharmac 11: 29-34
2. Ahmed I, Takeshita J (1996) Clonidine: a critical review of its role in the treatment of psychiatric disorders. CNS Drugs 6: 53-70
3. Aitken R C B (1969) Measurement of feelings using visual analogue scales. Proc R Soc Med 62: 989-999
4. Ariëns E J (1970) Reduction of drug action by drug combination. Progr Drug Res 14: 11-58
5. Bini G, Hagbarth K E, Hynniken P, Wallin B G (1980) Regional similarities and differences in thermoregulatory motor and sudomotor tone. J Physiol 306: 553-565
6. Bitsios P, Langley R W, Szabadi E, Bradshaw C M (1996a) Comparison of the effects of clonidine on tyramine- and methoxamine-evoked mydriasis in man. Br J Clin Pharmac 41: 269-275
7. Bitsios P, Szabadi E, Bradshaw C M (1996b) The inhibition of the pupillary light reflex by the threat of an electric shock: a potential laboratory model of human anxiety. J Psychopharmac 10: 279-287
8. Bitsios P, Szabadi E, Bradshaw C M (1996c) Comparison of the effects of psychological threat and clonidine on the kinetics of the pupillary light reflex in man. Br J Clin Pharmac 42: 269-270P
9. Bitsios P, Szabadi E, Bradshaw C M (1998) Sensitivity of the fearinhibited light reflex to diazepam. Psychopharmacology 135 in press
10. Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47: 211-218
11. Charney D S, Sternberg D E, Kleber H D, Heninger G R, Redmond D E, Jr (1981) The clinical use of clonidine in abrupt withdrawal from methadone. Archs Gen Psychiat 38: 1273-1277
12. Charney D S, Bremner J D, Redmond D E (1995) Noradrenergic neural substrates for anxiety and fear: clinical association based on preclinical research. In Bloom F E, Kupfer D J (eds), Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp. 387-396
13. 2-adrenoceptor antagonist RX 781094. Br J Clin Pharmac 14: 99-101
14. Clifford J M, Hoare R C, Jennings M, Nichols J D, Lynn A G (1989) Observations of the antagonism of clonidine-induced effects by efaroxan in healthy non-patient volunteers. Br J Clin Pharmac 28: 224-225P
15. 2-Adrenoceptors in panic and anxiety disorders. J Psychopharmac 10 (Suppl. 3): 26-34
16. Davis M (1992) The role of the amygdala in conditioned fear. In Aggleton J (ed.), The amygdala: neurobiological aspects of emotion, memory, and mental dysfunction. Wiley-Liss, New York, pp. 255-305
17. Davis M, Redmond D E, Baraban J M (1979) Noradrenergic agonists and antagonists effects on conditioned fear as measured by the potentiated startle paradigm. Psychopharmacology, 65: 111-118
18. Davis M, Falls W A, Campeau S, Kim M (1993) Fear-potentiated startle: a neural and pharmacological analysis. Behav Brain Res 58: 175-198
19. Fanciullacci M, Pietrini U, Fusco B M, Alessandrini M, Marabini S, Sicuteri F (1988) Does anisocoria by clonidine reflect a central sympathetic dysfunction in cluster headache? Clin Neuropharmac 11: 56-62
20. Foote S L, Aston-Jones G S (1995) Pharmacology and physiology of central noradrenergic systems. In Bloom F E, Kupfer D J (eds), Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp. 335-345
21. Glue P, Nutt D (1988) Clonidine challenge testing of alpha-2-adrenoceptor function in man: the effects of mental illness and psychotropic medication. Psychopharmacology 2: 119-137
22. Handley S L, Mithani S (1984) Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn Schmiedeberg's Arch Pharmac 327: 1-5
23. Heal D J (1990) The effects of drugs on behavioural models of central noradrenergic function. In Marsden C A, Heal D J (eds), Central noradrenaline receptors and psychotropic drugs. Blackwell Scientific Publications, Oxford, pp. 265-315
24. Hoehn-Saric R, Merchant A F, Keyser M L, Smith V K (1981) Effects of clonidine on anxiety disorders. Archs Gen Psychiat 38: 1278-1282
25. LeDoux J E, Iwata J, Cicchetti P, Reis D J (1988) Different projections of the central amygdaloid nucleus mediate autonomie and behavioral correlates of conditioned fear. J Neurosci 8: 2517-2529
26. Leung N K-C, Bradshaw C M, Szabadi E (1992) Effect of high ambient temperature on the kinetics of the pupillary light reflex in healthy volunteers. Br J Clin Pharmac 33: 458-460
27. Libet B, Gleason C A (1994) The human locus coeruleus and anxiogenesis. Brain Res 634: 178-180
28. Loewenfeld I E (1993a) Reflex integration: physiologic mechanisms. In The Pupil, Iowa State University Press, Iowa City, pp. 407-480
29. Loewenfeld I E (1993b) Pupillary pharmacology. In The Pupil, Iowa State University Press, Iowa City, pp. 683-827
30. MacDonald E, Ruskoaho H, Scheinin M, Virtanen R (1988) Therapeutic applications of drugs acting on alpha-adrenoceptors. Ann Clin Res 20: 298-310
31. MacDonald E, Kobilka B K, Scheinin M (1997) Gene targeting - homing in on α-adrenoceptor-subtype function. Trends Pharmac Sci 18: 211-219
32. Morley M J, Bradshaw C M, Szabadi E (1991) Effects of clonidine and yohimbine on the pupillary light reflex and carbachol-evoked sweating in healthy volunteers. Br J Clin Pharmac 31: 90-101
33. Mortlock S-A, Langley R W, Bradshaw C M, Szabadi E (1996) Effect of locally applied prazosin on the kinetics of the pupillary light reflex. Br J Clin Pharmac 42: 236-238
34. Nieuwenhuys R (1985) Chemoarchitecture of the brain. Springer, Berlin
35. Norris H (1971) The action of sedatives on brain-stem oculomotor systems in man. Neuropharmacology 10: 181-191
36. Redmond D E (1981) Clonidine and the primate locus coeruleus: evidence suggesting anxiolytic and anti-withdrawal effects. In Lal H, Fielding S (eds), Psychopharmacology of clonidine. Alan R. Liss, New York, pp. 147-164
37. Redmond D E (1982) Does clonidine alter anxiety in humans? Trends Pharmac Sci 3: 477-480
38. Reid J (1981) The clinical pharmacology of clonidine and related central antihypertensive agents. Br J Clin Pharmac 12: 295-302
39. Smith S A (1992) Pupil function: tests and disorders. In Bannister R, Mathias C J (eds) Autonomie failure (3rd edn). Oxford University Press, Oxford, pp. 393-412
40. 2-adrenoceptors. J Psychopharmac 10 (Suppl. 3): 6-18
41. Theofilopoulos N, McDade G, Szabadi E, Bradshaw C M (1995) Effects of reboxetine and desipramine on the kinetics of the pupillary light reflex. Br J Clin Pharmac 39: 251-255
42. Uhde T W, Stein M B, Vittone B J, Siever L J, Boulenger J-P, Klein E, Mellman T A (1989) Behavioral and physiologic effects of short-term and long-term administration of clonidine in panic disorder. Archs Gen Psychiat 46: 170-177
43. Warren J B, Dollery C T, Sciberras D, Goldberg M R (1991) Assessment of MK-467, a peripheral α-adrenergic receptor antagonist, with intravenous clonidine. Clin Pharmac Ther 50: 71-77